H Kropp
- Molecular Medicine top 0.2%
- Antibiotic Resistance in Bacteria 14
- Pharmacology top 0.5%
- Antibiotics Pharmacokinetics and Efficacy 16
- Infectious Diseases top 2%
- Antifungal resistance and susceptibility 5
- Antimicrobial Resistance in Staphylococcus 5
- Clinical Biochemistry top 2%
-
- Pneumocystis jirovecii pneumonia detection and treatment 3
- Pneumonia and Respiratory Infections 2
-
- Drug Transport and Resistance Mechanisms 2
-
- Blood disorders and treatments 2
- Co-authors
- Frederick M. KahanJon G. SundelofJean S. KahanPatrick J. CassidyJerome BirnbaumRichard HajduJ. J. JacksonJ. S. Macdonald
- Journals
- Antimicrobial Agents and Chemotherapy (14 papers)Journal of Medicinal Chemistry (2 papers)The Journal of Infectious Diseases (2 papers)
- Partner nations
- United StatesSwedenJapan
In The Last Decade
H Kropp
34 papers receiving 2.6k citations
Hit Papers
Peers
Comparison fields: 5 of 112
- Molecular Medicine 1.0k
- Applied Microbiology and Biotechnology 175
- Pharmacology 1.2k
- Infectious Diseases 713
- Clinical Biochemistry 171
Countries citing papers authored by H Kropp
This map shows the geographic impact of H Kropp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H Kropp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H Kropp more than expected).
Fields of papers citing papers by H Kropp
This network shows the impact of papers produced by H Kropp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H Kropp. The network helps show where H Kropp may publish in the future.
Co-authorship network
The 25 scholars most cited alongside H Kropp, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1999 | 17 | |
| 2 | 1999 | 67 | |
| 3 | 1998 | 57 | |
| 4 | 1997 | 6 | |
| 5 | 1996 | 13 | |
| 6 | 1996 | 45 | |
| 7 | 1996 | 7 | |
| 8 | 1995 | 6 | |
| 9 | Quantitative variations in beta-lactam antibiotic released endotoxin from Pseudomonas aeruginosa: in-vivo relevance. | 1995 | 1 |
| 10 | 1995 | 47 | |
| 11 | 1995 | 7 | |
| 12 | 1993 | 2 | |
| 13 | 1992 | 152 | |
| 14 | 1992 | 55 | |
| 15 | 1986 | 15 | |
| 16 | 1985 | 216 | |
| 17 | 1980 | 162 | |
| 18 | [A so-called coumarin necrosis in a child]. | 1973 | 1 |
| 19 | Phosphonomycin. V. Evaluation in mice. | 1969 | 9 |
| 20 | [Determination of sensitivity of bacteria against chemotherapeutics and antibiotics in bacterial infections]. | 1952 | 2 |
About H Kropp
H Kropp is a scholar working on Molecular Medicine, Pharmacology and Infectious Diseases, having authored 35 papers that have together received 2.9k indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (16 papers), Antibiotic Resistance in Bacteria (14 papers), Antifungal resistance and susceptibility (5 papers), Antimicrobial Resistance in Staphylococcus (5 papers), Pneumocystis jirovecii pneumonia detection and treatment (3 papers), Pneumonia and Respiratory Infections (2 papers), Drug Transport and Resistance Mechanisms (2 papers) and Blood disorders and treatments (2 papers). The work is most often cited by research in Molecular Medicine (1.0k citations), Applied Microbiology and Biotechnology (175 citations) and Pharmacology (1.2k citations). H Kropp has collaborated with scholars based in United States, Sweden and Japan. Frequent co-authors include Frederick M. Kahan, Jon G. Sundelof, Jean S. Kahan, Patrick J. Cassidy, Jerome Birnbaum, Richard Hajdu, J. J. Jackson, J. S. Macdonald, George K. Abruzzo and Ken Bartizal. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Journal of Medicinal Chemistry, The Journal of Infectious Diseases, The Journal of Antibiotics and Clinical Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.